PAMELA LACHS: Open Payments
NPI 1629507629 · GARDEN CITY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,576 in 83 payments from 17 companies in 2025. Trend: 2023 $2,248 · 2024 $3,575 · 2025 $3,576
Food & beverage: $3,418Education: $158
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $563 |
| ABBVIE INC. | 23 | $557 |
| GENZYME CORPORATION | 5 | $409 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $304 |
| UCB, Inc. | 4 | $289 |
| Incyte Corporation | 4 | $288 |
| LEO Pharma Inc. | 11 | $222 |
| Organon LLC | 3 | $160 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 2 | $158 |
| Regeneron Healthcare Solutions, Inc. | 2 | $149 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, Bimzelx, RINVOQ, ADBRY, Opzelura, Leqselvi.
Industry payments across NY — which companies pay providers there.
